Biofrontera Inc.
BFRI
$0.83
$0.022.32%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -17.57M | -16.59M | -11.53M | -17.76M | -12.84M |
| Total Depreciation and Amortization | 869.00K | 974.00K | 1.06M | 1.15M | 1.22M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 619.00K | 960.00K | -4.30M | 128.00K | -7.36M |
| Change in Net Operating Assets | 4.08M | 5.27M | 3.70M | 6.21M | 856.00K |
| Cash from Operations | -12.00M | -9.39M | -11.06M | -10.27M | -18.12M |
| Capital Expenditure | -4.00K | -5.00K | 44.00K | -10.00K | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 0.00 | -50.00K | 7.00K | 71.00K |
| Cash from Investing | -4.00K | -5.00K | -6.00K | -3.00K | 71.00K |
| Total Debt Issued | 4.05M | 4.05M | 4.05M | 4.05M | 11.70M |
| Total Debt Repaid | 0.00 | -298.00K | -2.45M | -4.32M | -13.81M |
| Issuance of Common Stock | 0.00 | 0.00 | 0.00 | 7.66M | 12.17M |
| Repurchase of Common Stock | -- | -- | -224.00K | -224.00K | -224.00K |
| Issuance of Preferred Stock | 8.50M | 0.00 | 7.66M | 7.66M | 7.66M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 8.50M | -- | -- | -- |
| Cash from Financing | 12.55M | 12.25M | 9.04M | 14.84M | 17.50M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 544.00K | 2.86M | -2.03M | 4.56M | -549.00K |